Eastern Bank Has $949,000 Holdings in The Clorox Company (NYSE:CLX)

Eastern Bank reduced its position in shares of The Clorox Company (NYSE:CLX) by 7.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,845 shares of the company’s stock after selling 462 shares during the quarter. Eastern Bank’s holdings in Clorox were worth $949,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in CLX. Fiduciary Alliance LLC grew its position in shares of Clorox by 64.9% in the 4th quarter. Fiduciary Alliance LLC now owns 2,432 shares of the company’s stock valued at $395,000 after acquiring an additional 957 shares during the period. Czech National Bank grew its position in shares of Clorox by 6.4% in the 4th quarter. Czech National Bank now owns 26,839 shares of the company’s stock valued at $4,359,000 after acquiring an additional 1,607 shares during the period. Graypoint LLC grew its position in shares of Clorox by 9.5% in the 4th quarter. Graypoint LLC now owns 4,269 shares of the company’s stock valued at $693,000 after acquiring an additional 370 shares during the period. ST Germain D J Co. Inc. grew its position in shares of Clorox by 7.5% in the 4th quarter. ST Germain D J Co. Inc. now owns 4,281 shares of the company’s stock valued at $695,000 after acquiring an additional 300 shares during the period. Finally, Wealth Enhancement Advisory Services LLC grew its position in shares of Clorox by 1.2% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 46,309 shares of the company’s stock valued at $7,544,000 after acquiring an additional 532 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on the stock. Jefferies Financial Group raised shares of Clorox from a “hold” rating to a “buy” rating and lifted their price objective for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Barclays lifted their target price on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Evercore ISI reduced their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and lifted their target price for the stock from $155.00 to $170.00 in a report on Wednesday, November 6th. Finally, StockNews.com downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $157.46.

Clorox Price Performance

Shares of NYSE:CLX opened at $157.32 on Tuesday. The firm has a 50 day moving average of $164.55 and a 200-day moving average of $156.00. The stock has a market capitalization of $19.47 billion, a PE ratio of 54.82, a PEG ratio of 3.04 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The Clorox Company has a 12 month low of $127.60 and a 12 month high of $171.37.

Clorox (NYSE:CLX) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business’s revenue for the quarter was up 27.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.49 EPS. On average, equities research analysts predict that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.10%. The ex-dividend date is Wednesday, January 29th. Clorox’s dividend payout ratio is 170.03%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.